ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of The Medicines Company
NEW YORK, Nov. 25, 2019 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by The Medicines Company (NASDAQ: MDCO) and its board of directors concerning the proposed acquisition of the company by Novartis AG (NYSE: NVS). Stockholders will receive $85.00 for each share of The Medicines Company stock that they hold. The transaction is valued at approximately $9.7 billion and is expected to close in the first quarter of 2020.
If you are a stockholder of The Medicines Company and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/mdco. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE Rowley Law PLLC
News published on and distributed by:
